Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1993-1-27
pubmed:abstractText
Nitric oxide has recently been implicated as the effector molecule that mediates IL-1 beta-induced inhibition of glucose-stimulated insulin secretion and beta-cell specific destruction. The pancreatic islet represents a heterogeneous cell population containing both endocrine cells (beta-[insulin], alpha-]glucagon], gamma[somatostatin], and PP-[polypeptide] secreting cells) and non-endocrine cells (fibroblast, macrophage, endothelial, and dendritic cells). The purpose of this investigation was to determine if the beta-cell, which is selectively destroyed during insulin-dependent diabetes mellitus, is both a source of IL-1 beta-induced nitric oxide production and also a site of action of this free radical. Pretreatment of beta-cells, purified by FACS with IL-1 beta results in a 40% inhibition of glucose-stimulated insulin secretion that is prevented by the nitric oxide synthase inhibitor, NG-monomethyl-L-arginine (NMMA). IL-1 beta induces the formation of nitric oxide by purified beta-cells as evidenced by the accumulation of cGMP, which is blocked by NMMA. IL-1 beta also induces the accumulation of cGMP by the insulinoma cell line Rin-m5F, and both NMMA as well as the protein synthesis inhibitor cycloheximide prevent this cGMP accumulation. Iron-sulfur proteins appear to be intracellular targets of nitric oxide. IL-1 beta induces the formation of an iron-dinitrosyl complex by Rin-m5F cells indicating that nitric oxide mediates the destruction of iron-sulfur clusters of iron containing enzymes. This is further demonstrated by IL-1 beta-induced inhibition of glucose oxidation by purified beta-cells, mitochondrial aconitase activity of dispersed islet cells, and mitochondrial aconitase activity of Rin-m5F cells, all of which are prevented by NMMA. IL-1 beta does not appear to affect FACS-purified alpha-cell metabolic activity or intracellular cGMP levels, suggesting that IL-1 beta does not exert any effect on alpha-cells. These results demonstrate that the islet beta-cell is a source of IL-1 beta-induced nitric oxide production, and that beta-cell mitochondrial iron-sulfur containing enzymes are one site of action of nitric oxide.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1371193, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1384465, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1645341, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1657959, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1683279, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1689048, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1696255, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1715579, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1832112, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1852778, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1884886, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-1903597, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2025250, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2031271, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2073784, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2114318, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2127391, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2137789, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2153975, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2154196, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2203826, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2265709, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2405856, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2432129, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2440648, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2521822, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-2862019, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-3142779, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-3242600, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-3297891, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-3308437, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-3530029, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-3745439, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-3901813, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-5318831, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-6292238, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-6366468, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-7181105, http://linkedlifedata.com/resource/pubmed/commentcorrection/1334975-942051
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2384-91
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1992
More...